Whipple's disease with muscle impairment

Muscle and Nerve

Volumn 34, Issue 6, 2006, Pages 794-798

  Puget, Marie ^a   Iwaz, Jean ^b   Tristan, Anne ^c   Streichenberger, Nathalie ^d  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c LOUIS PRADEL HOSPITAL   (France)

^d HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Inflammation; Myalgia; Myopathy; Tropheryma whipplei; Whippie's disease

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CEFTRIAXONE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; GADOLINIUM; METHOTREXATE; METHYLPREDNISOLONE; MORPHINE; PREDNISONE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG TREATMENT FAILURE; DUODENUM; GENERAL CONDITION IMPROVEMENT; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTESTINE LIPODYSTROPHY; LEG EDEMA; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE DISEASE; MYALGIA; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY INFLAMMATION; POLYARTHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYMPTOM; TROPHERYMA WHIPPELII;

ACTINOMYCETALES; ACTINOMYCETALES INFECTIONS; AGED; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; DIAGNOSIS, DIFFERENTIAL; DNA, BACTERIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; MUSCULAR DISORDERS, ATROPHIC; TREATMENT OUTCOME; WHIPPLE DISEASE;

EID: 33845328422     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20650     Document Type: Article

References (26)

1. Bai JC, Mazure RM, Vazquez H, Niveloni SI, Smecuol E, Pedreira S, et al. Whipple's disease. Clin Gastroenterol Hepatol 2004;2:849-860.
2. Baisden BL, Lepidi H, Raoult D, Argani P, Yardley JH, Dumler JS. Diagnosis of Whipple's disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol 2002;118:742-748.
3. Black-Schaffer B. The tinctorial demonstration of a glycoprotein in Whipple's disease. Proc Soc Exp Biol Med 1949;72: 225-227.
4. Dobbins WO III. Whipple's disease. Springfield, IL: Charles C. Thomas; 1987. 242 p.
5. Fenollar F, Fournier PE, Robert C, Raoult D. Use of genome selected repeated sequences increases the sensitivity of PCR detection of Tropheryma whipplei. J Clin Microbiol 2004;42:401-403.
6. Gordon RY, Blumberg E, Brozena SC, Fyfe B. Whipple pancardius as a cause of heart failure. Ann Intern Med 2004;140: 673-674.
7. Gunia S, Behrens MH, Stosiek P. A rare course of Whipple's disease with atypical cardiac manifestation. APMIS 2004;112: 222-224.
8. Helliwell TR, Appleton RE, Mapstone NC, Davidson J, Walsh KP. Dermatomyositis and Whipple's disease. Neuromuscul Disord 2000;10:46-51.
9. Julien J, Leparc-Goffart I, Lina B, Fuchs F, Foray S, Janatova I, etal. Postpolio syndrome: poliovirus persistence is involved in the pathogenesis. J Neurol 1999;246:472-476.
10. Lepidi H, Fenollar F, Gerolami R, Mege JL, Bonzi MF, Chappuis M, et al. Whipple's disease: immunospecific and quanti-tative immunohistochemical study of intestinal biopsy specimens. Hum Pathol 2003;34:589-596.
11. Mahnel R, Marth T. Progress, problems, and perspectives in diagnosis and treatment of Whipple's disease. Clin Exp Med 2004;4:39-43.
12. Marth T, Raoult D. Whipple's disease. Lancet 2003;361:239-246.
13. Marth T, Strober W. Whipple's disease. Semin Gastrointest Dis 1996;7:41-48.
14. Melchers W, de Visser M, Jongen P, van Loon A, Nibbeling R, Oostvogel P, et al. The postpolio syndrome: no evidence for poliovirus persistence. Ann Neurol 1992;32:728-732.
15. Misbah SA, Mapstone NP. Whipple's disease revisited. J Clin Pathol 2000;53:750-755.
16. Misbah SA, Ozols B, Franks A, Mapstone N. Whipple's disease without malabsorption: new atypical features. Q J Med 1997; 90:765-772.
17. Nishimura JK, Cook BE Jr, Pach JM. Whipple disease presenting as posterior uveitis without prominent gastrointestinal symptoms. Am J Ophthalmol 1998;126:130-132.
18. Orssaud C, Poisson M, Gardeur D. Orbital myositis, recurrence of Whipple's disease. J Fr Ophtalmol 1992;15:205-208.
19. Pron B, Poyart C, Abachin E, Fest T, Belanger C, Bonnet C, et al. Diagnosis and follow-up of Whipple's disease by amplification of the 16S rRNA gene of Tropheryma whippelii. Eur J Clin Microbiol Infect Dis 1999;18:62-65.
20. Raoult D, Birg ML, La Scola B, Fournier PE, Enea M, Lepeidi H, et al. Cultivation of the bacillus of Whipple's disease. N Engl J Med 2000;324:620-625
21. Relman DA, Schmidt TM, MacDermott RP, Falcow S. Identification of the uncultured bacillus of Whipple's disease. N EnglJ Med 1992;327:293-301.
22. Ring S, Schneider T, Marth T. Mucosal immune response to Tropheryma whipplei. Int J Med Microbiol 2003;293:69-76.
23. Stamboulis E, Manta P, Kararizou E, Grivas I. Whipple's disease with tubular aggregates in asymptomatic muscle. Clin Neuropathol 1993;12:121-124.
24. Swash M, Schwartz MS, Vandenburg MJ, Pollock DJ. Myopathy in Whipple's disease. Gut 1977;18:800-804.
25. Vital-Durand D, Lecomte C, Cathebras P. Whipple's disease: clinical review of 52 cases. Medicine (Baltimore) 1997;90: 765-772.
26. Yardley JH, Hendrix TR. Combined electron and light microscopy in Whipple's disease: demonstration of "bacillary bodies" in the intestine. Bull Johns Hopkins Hosp 1961;109:80-98.